Form 4 Tracker
VERTEX PHARMACEUTICALS INC / MA
VRTX

86 insider filings · Latest: Jun 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 18, 2026Feb 19 9:03 PMKristen AmbroseSVP & Chief Accounting Officer
Sale
638$473.68$302.2K7,750(D)

View →

Feb 17, 2026Feb 19 9:03 PMKristen AmbroseSVP & Chief Accounting Officer
Sale
1,557$489.46$762.1K8,388(D)

View →

Feb 13, 2026Feb 18 9:43 PMOurania TatsisEVP, Chief Reg. & Quality Off.
Sale
1,500$499.99$750.0K46,132(D)

View →

Feb 13, 2026Feb 18 9:26 PMJonathan BillerEVP and Chief Legal Officer
Sale
988$499.00$493.0K16,838(D)

View →

Feb 13, 2026Feb 18 9:23 PMSangeeta N. BhatiaDirector
Sale
266$500.00$133.0K4,299(D)

View →

Feb 18, 2026Feb 18 5:28 PMTatsis Ourania
Proposed Sale
368$473.68$174.3K

View →

Feb 18, 2026Feb 18 3:46 PMBiller Jonathan
Proposed Sale
1,244$473.68$589.3K

View →

Feb 18, 2026Feb 18 3:17 PMBunnage Mark E.
Proposed Sale
1,182$473.68$559.9K

View →

Feb 18, 2026Feb 18 2:55 PMAtkinson Edward Morrow III
Proposed Sale
817$473.68$387.0K

View →

Feb 17, 2026Feb 17 8:26 PMBunnage Mark E.
Proposed Sale
2,437$489.46$1.2M

View →

Feb 17, 2026Feb 17 7:34 PMTatsis Ourania
Proposed Sale
609$489.46$298.1K

View →

Feb 17, 2026Feb 17 6:52 PMBiller Jonathan
Proposed Sale
2,476$489.46$1.2M

View →

Feb 17, 2026Feb 17 6:20 PMAtkinson Edward Morrow III
Proposed Sale
2,031$489.46$994.1K

View →

Feb 13, 2026Feb 13 7:59 PMBiller Jonathan
Proposed Sale
988$499.00$493.0K

View →

Feb 13, 2026Feb 13 7:54 PMBhatia Sangeeta N.
Proposed Sale
266$500.00$133.0K

View →

Feb 13, 2026Feb 13 7:43 PMTatsis Ourania
Proposed Sale
1,500$499.99$750.0K

View →

Feb 11, 2026Feb 12 10:08 PMOurania TatsisEVP, Chief Reg. & Quality Off.
Sale
466$460.43$214.6K51,436(D)

View →

Feb 11, 2026Feb 12 9:56 PMMark E. BunnageEVP, Chief Scientific Officer
Sale
2,021$460.43$930.5K12,914(D)

View →

Feb 11, 2026Feb 12 9:52 PMJonathan BillerEVP and Chief Legal Officer
Sale
1,925$460.43$886.3K20,819(D)

View →

Feb 11, 2026Feb 12 9:50 PMEdward Morrow Atkinson IIIEVP, Chief Technical Ops. Off.
Sale
1,751$460.43$806.2K22,046(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 1, 2026May 5 9:44 PMSuketu UpadhyayDirector
Grant/Award
3,662$424.453,595.156(D)

View →

May 1, 2026May 5 9:37 PMNancy ThornberryDirector
Grant/Award
1,831$424.45398(D)

View →

May 1, 2026May 5 9:29 PMJennifer SchneiderDirector
Grant/Award
2,229$424.45796(D)

View →

May 1, 2026May 5 9:24 PMBruce I SachsDirector
Grant/Award
2,866$424.452,866(D)

View →

May 1, 2026May 5 9:18 PMDiana MckenzieDirector
Grant/Award
7967,787.483(D)

View →

May 1, 2026May 5 9:06 PMMichel LagardeDirector
Grant/Award
2,866$424.452,866(D)

View →

May 1, 2026May 5 8:58 PMAlan M GarberDirector
Grant/Award
1,433$424.451,433(D)

View →

May 1, 2026May 5 8:54 PMLloyd CarneyDirector
Grant/Award
2,866$424.452,866(D)

View →

Apr 15, 2026Apr 17 8:20 PMSuketu UpadhyayDirector
Grant/Award
80.5082,799.156(D)

View →

Apr 15, 2026Apr 17 8:17 PMBruce I SachsDirector
Grant/Award
107.34515,671.866(D)

View →

Apr 15, 2026Apr 17 8:14 PMAlan M GarberDirector
Grant/Award
33.89833.898(D)

View →

Feb 19, 2026Feb 23 9:21 PMAmit SachdevEVP Chief Patient & Ext Af Off
Option Exercise
48,505$187.530(D)

View →

Jan 15, 2026Jan 20 9:48 PMSuketu UpadhyayDirector
Grant/Award
80.3162,718.648(D)

View →

Jan 15, 2026Jan 20 9:45 PMBruce I SachsDirector
Grant/Award
107.08815,564.521(D)

View →